Successful use of mycophenolate mofetil and prednisone in a 14-year-old girl with acquired hemophilia A

Thrombosis and Haemostasis

Volumn 93, Issue 4, 2005, Pages 792-793

  Eisert, Susanne ^a   Mosler, Katharina ^a   Laws, Hans J ^a   Göbel, Ulrich ^a  

^a HEINRICH HEINE UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

BLOOD CLOTTING FACTOR 8 ANTIBODY; BLOOD CLOTTING FACTOR 8 INHIBITOR; BLOOD CLOTTING FACTOR 8C; IMMUNOGLOBULIN; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISONE; STEROID;

ABDOMINAL PAIN; ADOLESCENT; ANAMNESIS; ARTICLE; BODY WEIGHT DISORDER; CASE REPORT; CLINICAL EXAMINATION; CUSHINGOID SYNDROME; DRUG USE; ERYTHROCYTE SEDIMENTATION RATE; FEMALE; FOLLOW UP; HEMATURIA; HEMOPHILIA A; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; PRIORITY JOURNAL; PROTHROMBIN TIME; SIDE EFFECT; WEIGHT GAIN;

EID: 16844383435     PISSN: 03406245     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-0037-1616782     Document Type: Article

References (7)

1. Green D, Lechner K. A survey of 215 non-hemophilic patients with inhibitors to factor VIII. Thromb Haemost 1981; 45: 200-3.
2. Hay CR, Negrier C, Ludlam CA. The treatment of bleeding in acquired haemophilia with recombinant factor VIIa: a multicentre study. Thromb Haemost 1997; 78: 1463-7.
3. Green D, Rademaker AW, Briet E. A prospective, randomized trial of prednisone and cyclophosphamide in the treatment of patients with factor VIII autoantibodies. Thromb Haemost 1993; 70: 753-7.
4. Delgado J, Jimenez-Yuste V, Hernandez-Navarro F, et al. Acquired haemophilia: review and meta-analysis focused on therapy and prognostic factors. Br J Haematol 2003; 121: 21-35.
5. Moraca RJ, Ragni MV. Acquired anti-F.VIII inhibitors in children. Haemophilia 2002;8: 28-32.
6. Filler G, Hansen M, LeBlanc C, et al. Pharmacokinetics of mycophenolate mofetil for autoimmune disease in children. Pediatr Nephrol 2003; 18: 445-9.
7. von Depka M, Huth-Kuchne A. Immunoadsorption with anti-immunoglobulin antibodies using Ig TheraSorb columns. In: Inhibitors inpatients with haemophilia. Blackwell Science Ltd 2002; 199-205.